“…Metabolomics, as a sensitive barometer of external stimulation and pathological insults, provides a powerful strategy for screening environmental exposures-related and adverse outcomes-related metabolites with no prior hypothesis and contributes to the characterization of their complicated mechanisms from a metabolic perspective (Huang et al, 2018;Valvi et al, 2020;You et al, 2021). To date, some metabolomics studies on PBDE exposure effects have addressed the compelling metabolic changes in the animal and cell lines models (Chi et al, 2011;Ji et al, 2019a;Tang et al, 2019;Wei et al, 2018;Xu et al, 2021;Yang et al, 2019), concerning on breast cancer (Wei et al, 2018), hepatic steatosis (Yang et al, 2019), neurotoxicity (Ji et al, 2019a;Tang et al, 2019), reproductive toxicity (Xu et al, 2021) and embryo-toxicity (Chi et al, 2011). In addition, a few studies have used metabolomics approach to investigate the underlying metabolism disorders of adverse pregnancy outcomes, such as intrauterine growth restriction (IUGR) (Favretto et al, 2012) and spontaneous preterm birth (SPB) (Elshenawy et al, 2020).…”